Big Pharma, Covir Policies And Rising Cancer Questions -

During the COVID-19 pandemic, major pharmaceutical companies generated unprecedented revenue from vaccines and treatments while public health measures disrupted routine medical care. Reports documented delays in cancer screenings, diagnoses, and treatments across multiple countries. At the same time, pharmaceutical firms secure